All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate Bonds

Glaxo bags €2.5bn, all negative, Dea €4bn


Most investment grade corporate bonds issued over the past weeks have had intermediate to longer tenors, but on Monday issuance tilted towards the shorter end, as GlaxoSmithKline printed two negative yielding tranches.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree